Literature DB >> 22938940

ER stress in diffuse large B cell lymphoma: GRP94 is a possible biomarker in germinal center versus activated B-cell type.

Jerina Boelens1, Jean-Philippe Jais, Barbara Vanhoecke, Ilse Beck, Heleen Van Melckebeke, Jan Philippé, Marc Bracke, Fabrice Jardin, Josette Brière, Karen Leroy, Fritz Offner, Sofie Lust.   

Abstract

The process of B-cell development is characterized by the activation of the unfolded protein response. Under certain circumstances, the unfolded protein response can be manipulated in a cell death-inducing way. Therefore, tackling the unfolded protein response might be an attractive strategy in the treatment of diffuse large B-cell lymphomas. Our research showed more basal unfolded protein response activity and differences in the inducibility of ER stress in activated B-cell versus germinal center cell lines. Moreover, the diffuse large B cell lymphoma patient data revealed that the glucose-regulated protein 94 is new potential discriminator for diffuse large B cell lymphoma.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22938940     DOI: 10.1016/j.leukres.2012.08.017

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  2 in total

1.  Glucose-regulated protein 94 is a novel glioma biomarker and promotes the aggressiveness of glioma via Wnt/β-catenin signaling pathway.

Authors:  Tieyi Hu; Niqi Xie; Chuan Qin; Jiasheng Wang; Yi You
Journal:  Tumour Biol       Date:  2015-06-25

2.  Grp94 in complexes with IgG is a soluble diagnostic marker of gastrointestinal tumors and displays immune-stimulating activity on peripheral blood immune cells.

Authors:  Elisa Tramentozzi; Erlis Ruli; Imerio Angriman; Romeo Bardini; Michela Campora; Vincenza Guzzardo; Rita Zamarchi; Elisabetta Rossi; Massimo Rugge; Paola Finotti
Journal:  Oncotarget       Date:  2016-11-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.